Last $43.81 USD
Change Today +0.03 / 0.07%
Volume 6.5M
As of 8:04 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for abbott laboratories (ABT)

Although debt as a percent of total capital decreased at Abbott Laboratories over the last fiscal year to 20.61%, it is still in-line with the Healthcare Equipment and Supplies industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Cash Collection is a strong suit as the company is more effective than most in the industry. As of the end of 2013, its uncollected receivables totaled $4.0B USD, which, at the current sales rate provides a Days Receivables Outstanding of 96.89. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 118.44 days.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Assets    
Cash and Equivalents3,648.46,812.810,802.03,475.0
Short-Term Investments1,803.11,284.54,372.04,623.0
TOTAL CASH AND SHORT TERM INVESTMENTS5,451.58,097.415,174.08,098.0
Accounts Receivable7,184.07,683.97,613.03,986.0
TOTAL RECEIVABLES7,184.07,683.97,613.03,986.0
Inventory3,188.73,284.23,793.02,693.0
Prepaid Expenses1,419.81,722.71,637.01,420.0
Deferred Tax Assets, Current3,076.12,700.52,986.02,528.0
Other Current Assets1,997.5280.0120.0522.0
TOTAL CURRENT ASSETS22,317.523,768.831,323.019,247.0
Gross Property Plant and Equipment17,374.318,016.618,929.012,870.0
Accumulated Depreciation-9,403.3-10,142.6-10,866.0-6,965.0
NET PROPERTY PLANT AND EQUIPMENT7,971.07,874.08,063.05,905.0
Goodwill15,930.115,705.415,774.09,772.0
Long-Term Investments440.0976.2459.0206.0
Deferred Tax Assets, Long Term1,763.61,962.93,028.02,022.0
Other Intangibles12,151.69,989.68,588.05,735.0
Other Long-Term Assets------66.0
TOTAL ASSETS60,573.960,276.967,235.042,953.0
    
LIABILITIES & EQUITY    
Accounts Payable1,535.81,721.11,797.01,026.0
Accrued Expenses6,943.46,806.17,816.04,006.0
Short-Term Borrowings3,699.81,667.91,467.02,659.0
Current Portion of Long-Term Debt/Capital Lease2,695.01,706.9924.0514.0
Current Income Taxes Payable1,307.7514.9655.0175.0
Other Current Liabilities, Total1,080.73,063.3621.01,127.0
TOTAL CURRENT LIABILITIES17,262.415,480.213,280.09,507.0
Long-Term Debt12,559.512,039.818,085.03,388.0
Minority Interest88.386.392.096.0
Pension & Other Post-Retirement Benefits2,425.03,301.04,871.01,818.0
Deferred Tax Liability Non-Current1,112.0703.0710.0466.0
Other Non-Current Liabilities4,449.84,226.73,476.02,507.0
TOTAL LIABILITIES37,808.735,750.740,422.017,686.0
Common Stock8,744.79,817.111,755.012,048.0
Retained Earnings19,215.820,907.424,151.021,979.0
Treasury Stock-3,916.8-3,687.5-5,591.0-6,844.0
Comprehensive Income and Other-1,366.8-2,597.2-3,594.0-2,012.0
TOTAL COMMON EQUITY22,676.824,439.826,721.025,171.0
TOTAL EQUITY22,765.124,526.126,813.025,267.0
TOTAL LIABILITIES AND EQUITY60,573.960,276.967,235.042,953.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:US $43.81 USD +0.03

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $259.75 USD +1.26
Eli Lilly & Co $67.36 USD +0.56
General Mills Inc $51.85 USD +0.21
Novo Nordisk A/S kr265.80 DKK +2.00
Thermo Fisher Scientific Inc $126.54 USD +1.96
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 34.4x
Price/Sales 3.0x
Price/Book 2.9x
Price/Cash Flow 24.3x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.